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1. Introduction 
Human Papillomavirus (HPV) is a DNA virus, belonging to papillomaviridae family. Its role in 
ethiopathogenesis of ano-genital cancers has been largely documented. On the contrary, HPV status 
in Oropharyngeal Squamous Cell Carcinoma (OPSCC) presents several controversies, supporting by 
a substantial heterogeneity in HPV prevalence among studies and clinical reports. These 
uncertainties are primarily related to two strongly interconnected reasons: 
1. a non-univocal topographical classification of the OPSCC; 
2. an extreme heterogeneity of the diagnostic procedures used to detect HPV status [1]. 
In respect to the last issue, there are several techniques to investigate HPV in human samples, 
with advantages and disadvantages related to clinical applicability and sensitivity/specificity in 
relation to HPV oncological activity. Polymerase Chain Reaction (PCR) is the most sensitivity and 
widely used method to detect and to genotype HPV. However, p16 immunohistochemistry (IHC) is 
considered a more versatile tool to indirectly measure the HPV transcriptional activity. For these 
reasons, its use was proposed by the 8th edition of TNM classification to stage the Head and Neck 
Squamous Cell Carcinomas (HNSCCs), in relation to a better prognosis of HPV positive (+ve) OPSCC 
recently supported in literature [2,3]. However, there are several studies reporting the low specificity 
of p16 IHC in relation to HPV status, potentially conditioning the appropriate treatments of patients 
with OPSCCs [4,5]. In this scenario, the aim of this abstract is to report a case of patient with p16 
negative (-ve) OSCC, with HPV positivity by PCR investigation both in histological and on 
cytological samples. 
2. Case Report 
A Caucasian man of 61-years old, with any diseases or comorbidities noteworthy, referred to 
our Unit of Oral Medicine (Di.Chir.On.S./UNIPA) for the diagnostic assessment of a asymptomatic 
verrucous lesion localized at the right retromolar trigon (Figure 1). 
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Figure 1. Verrucous lesion localized at the right retromolar trigon. 
After informed consent, the patient underwent to: (i) oral rinse for HPV investigation (by PCR); 
and (ii) incisional biopsy both for HPV identification (by PCR and p16 IHC) and histological 
diagnosis. For PCR investigation, the HPV-DNA was extracted from oral rinse and biopsy sample 
with the use of the QIAamp Mini Kit (Qiagen). HPV genotypes were identified by the Ampliquality 
HPV-type express v3.0. 
The histological reports was: squamous carcinoma/p16 IHC-ve. 
On the contrary the microbiological examinations indicate a HPV positive status, supported by 
HR (High Risk) genotype 67 in both examined samples. 
3. Conclusions 
We report a case of confirmed diagnosis of HPV-DNA+ve/p16-ve OSCC at the right retromolar 
trigon. Exclusively according to the results of p16 IHC, the patient would have been resulted as 
negative HPV OSCC with a specific treatment. On the contrary, the use of more accurate technique 
of HPV investigation, highlighted a HPV-HR positivity. 
This status, in addition to other therapeutic and monitoring oncological approaches potentially 
prospective, presupposes a specific management of the infectious condition (i.e., genital 
investigation, also for the partner/s) which, in the absence of the supplementary microbiological 
investigations conducted, would have been precluded. 
In conclusion, it would be appropriate to consider, particularly for SCC in proximity to 
oropharyngeal areas, the necessity to use a combination of techniques (not only p16 IHC) for HPV 
status identification. 
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